Будем здоровы
Вы хотите отреагировать на этот пост ? Создайте аккаунт всего в несколько кликов или войдите на форум.
Будем здоровы

Трансфер факторы в нашей жизни
 
ФорумФорум  ПорталПортал  ПоискПоиск  РегистрацияРегистрация  Вставить фото  Вход  
Каждый вторник в 12.00 (время Московское) конференция применение Трансфер факторов http://www.hotconference.com/conference,21584380
в 19.00 по Москве в пятницу и в воскресенье интернет-конференции. http://www.hotconference.com/conference,21584380
Like
Партнеры
Последние темы
» Хочу купить папку
Библиография  Emptyавтор demko122 Ср Янв 17, 2018 10:08 am

» ООО «Инновационная мастерская Отче Савва» https://o-savva.ru/
Библиография  Emptyавтор Artyom1993 Ср Ноя 29, 2017 4:25 pm

» Пробиотики в гинекологии: профилактика и лечение воспалительных заболеваний
Библиография  Emptyавтор lusasidorova Вт Ноя 28, 2017 6:52 am

» Новый стул в комнату
Библиография  Emptyавтор demko122 Пн Окт 30, 2017 4:11 pm

» Вы можете и должны быть красивыми! Специалисты центра Vita работают для вас!
Библиография  Emptyавтор klinikavita Чт Дек 15, 2016 4:41 pm

» Мужская проблема!
Библиография  Emptyавтор demko122 Чт Дек 08, 2016 6:44 pm

» Душевые кабины
Библиография  Emptyавтор demko122 Вт Дек 06, 2016 11:08 am

» Юридическая компания
Библиография  Emptyавтор demko122 Пт Авг 26, 2016 10:32 pm

» Akitut.ru - магазин продажи аккаунтов Vk.com
Библиография  Emptyавтор demko122 Пт Авг 26, 2016 9:47 pm

» Стратегии для достижения успеха, Алимова Л.
Библиография  Emptyавтор demko122 Вс Май 08, 2016 8:17 pm

» Душевые кабины
Библиография  Emptyавтор demko122 Ср Янв 20, 2016 4:35 pm

» Покупал шкаф
Библиография  Emptyавтор demko122 Ср Янв 13, 2016 6:52 pm

Опрос
Как вы заботитесь о своем здоровье?
Закаляюсь
Библиография  Vote_lcap0%Библиография  Vote_rcap
 0% [ 0 ]
Правильно питаюсь
Библиография  Vote_lcap0%Библиография  Vote_rcap
 0% [ 0 ]
Соблюдаю режим дня
Библиография  Vote_lcap0%Библиография  Vote_rcap
 0% [ 0 ]
Использую природные средства для укрепления иммунитета
Библиография  Vote_lcap0%Библиография  Vote_rcap
 0% [ 0 ]
Использую Трансфер фактор
Библиография  Vote_lcap100%Библиография  Vote_rcap
 100% [ 3 ]
Всего проголосовало : 3
Ключевые слова
Октябрь 2021
ПнВтСрЧтПтСбВс
    123
45678910
11121314151617
18192021222324
25262728293031
КалендарьКалендарь
Поиск
 
 

Результаты :
 
Rechercher Расширенный поиск
Статистика
Всего зарегистрированных пользователей: 80
Последний зарегистрированный пользователь: Chielusttisi

Наши пользователи оставили сообщений: 612 в 467 сюжете(ах)

 

 Библиография

Перейти вниз 
АвторСообщение
Татьяна Самарцева

Татьяна Самарцева

Сообщения : 179
Дата регистрации : 2011-01-13
Возраст : 42
Откуда : Оренбург

Библиография  Empty
СообщениеТема: Библиография    Библиография  EmptyЧт Янв 27, 2011 4:13 am

Библиография Трансфер Фактора http://www.shirleys-wellness-cafe.com/russian/transfer-factor-russianlit26.htm

1. Adachi K; Nanba H; Kuroda H. “Potentiation of host-mediated antitumor activity in mice by beta-glucan obtained from Crifola frondosa (maitake).” Chem Pharm Bull (Tokyo), 1987, 35(1), 262-70.

2. Alam R “A brief review of the immune system.” Prim Care. 1998; Dec. 25(4):727-38Tenover FC, McGowan JE. “Reasons for the emergence of antibiotic resistance.” Am J Med Sci. 1996; 311(1): 9-16.

3. Albright JW, Albright JF. “Impaired Natural Killer cell function as a consequence of aging.” Exp Gerontol, 1998; 33(1-2): 13-25.

4. Ayala-de ha Cruz MC, Rodriguez-Padilla C. Tamez-Cuerra R. “Management of Hypereosinophilia with the Transfer Factor.” XIth international Congress on Trans fer Factor, 1—4 MAR 1999, Monterrey, Mexico

5. Ayala-de La Cruz MC, Rodriguez-Padilla C, Tamez-Cuerra R. “The Use of Transfer Factor in a Case of Refractive Urinary Tract Infection.” Xlth International Congress on Transfer Factor, 1—4 MAR 1999, Monterrey, Mexico

6. Ayala-de Ia Cruz MC, Rodriguez-Padilla C, Tamez­Cuerra R. “The Transfer Factor in the Management of a Case of Encephalitis Caused by Coccidioides Immitis.” XIth International Congress on Transfer Factor, 1-4 MAR 1999, Monterrey, Mexico

7. Ayala-de Ia Cruz MC, Rodriguez-Padilla C, Tamez-Cuerra R. “Efficacy of the Transfer Factor in the Severely Infected Pediatric Patient.” XIth International Congress on Transfer Factor, 1—4 MAR 1999, Monterrey, Mexico

8. Azghani AO, Williams I, Holiday DB, Johnson AR. “A beta-linked mannan inhibits adherence of Pseudomonas aeruginosa to human lung epithelial cells.” Glycobiology. 1995; 5(1): 39-44.

9. Awad AB, Downie A, Fink CS, Kim U. “Dietary phytosterol inhibits the growth and metastasis of MDA-MB-231 human breast cancer cells grown in SCID mice.” Anticancer Res 2000; 20(2A):821-4.

10. Awad AB, Fink CS. “Phytosterols as anticancer dietary components: evidence and mechanism of action.” J Nutr. 2000; 130 (9), 2127-30.

11. Awad AB, Downie AC, Fink CS. “Inhibition of growth and stimulation of apoptosis by beta-sistosterol treatment of MDA-MB-231 human breast cancer cells in culture.” Int J Mol Med 2000; 5(5):541-5

12. .Awad AB, Gan Y, Fink CS. “Mechanistic studies are helping to explain the protective effects of beta-sitosterol, a plant sterol, on growth, protein phosphatase 2A, and phospholipase D in LNCaP cells.” Nutr Cancer. 2000; 36(1): 74-8.

13. Awad AB, Begdache LA, Fink CS. “Effect of sterols and fatty acids on growth and triglyceride accumulation in 3T3-L1 cells.” J Nutr Biochem. 2000;11(3):153-158.

14. Barbour EK, Hamadeh SK, Chanem DA, Haddad JJ, Safieh-Carabedian B. “Humoral and cell-mediated immunopotentiation in vaccinated chicken layers by thymic hormones and zinc.” Vaccine. 1998; 16(17): 1650-5.

15. Bao ZD. Wu ZC. Zheng F. “Amelioration of aminoglycoside nephrotoxicity by Cordyceps sinensis in old patients.” Chung Kuo Chung Hsi I Chieh Ho Tsa Chih. 1994; 14(5): 271-3, 259

16. .Becker M, Staab D, Von Bergmann K. “Treatment of severe familial hypercholesterolemia in childhood with sitosterol and sitostanol.” J Pediatr 1993, 122(2): 292-6

17. Beilharz MW, McDonald W, Watson MW, Heng J, McGeachie J, Lawson CM. “Low-dose oral type I interferons reduce early virus replication of murine cytomegalovirus in vivo.” J Interferon Cytokine Res, 1997; 17(10): 625-30

18. Berron R, Almendarez C, Rosiles C. “Suppurative Adenopathy by Salmonell B Treated with Transfer Factor. Case Report.” XIth International Congress on Trans fer Factor, 1—4 MAR 1999, Monterrey, Mexico.

19. Bernhisel-Broadhent J, Yolken RH, Sampson HA. “Allergenicity of orally administered immunoglobulin preparations in food-allergic children.” Pediatrics 1991; 87(2): 208-14.

20. Bernard H, et al. Int Arch Allergy Immunol, 1998; 115: 235-44. Docena CH, et al. Allergy 1996; 51: 412-6. Wal JM. Adv Exp Med Biol 1995; 371B: 879-81. Dean T. EurJ Clin Nutr 1995; 49 (Suppl 1): S19-25.

21. Ben Eliyahu S, Page CC, Yirmiya R, Shakhar C. “Evidence that stress and surgical interventions promote tumor development by suppressing Natural Killer cell activity.” IntJ Cancer. 1999; 80(6): 880-8.

22. Berges RR, Windeler J, Trampisch HJ, Senge T. “Randomised, placebo-controlled, double-blind clinical trial of beta-sitosterol in patients with benign prostatic hyperplasia. Beta-sitosterol Study Group.” Lancet 1995; 345(8964):1529-32.

23. Berges RR, Kassen A, Senge T. “Treatment of symptomatic benign prostatic hyperplasia with beta-sistosterol: an 18-month follow-up.” BJU Int. 2000; May 85(7):842-6

24. Bock K, Sabin N. The Road to Immunity. Pocket Books, New York, 1997, Chp.3

25. Brodsky FM, Lem L, Solache A, Bennett EM. “Human pathogen subversion of antigen presentation.” Immunol Rev. 1999; 168: 199-215.

26. Bouic PJ, Etsebeth S, Liebenberg RW, Albrecht CF, Pegel K, Van Jaarsveld PP. “Beta-Sitosterol and beta-sitosterol glucoside stimulate human peripheral blood lymphocyte proliferation: implications for their use as an immunomodulatory vitamin combination Int J Immunopharmacol 1996;18(12):693-700

27. .Bouic PJ, Lamprecht JH. “Plant sterols and sterolins: a review of their immune-modulating properties.” Altern-Med-Rev. 1999; 4(3): 170-7

28. Bouic PJ, Clark A, Lamprecht J, Freestone M, Pool EJ, Liebenberg RW, Kotze D, van-Jaarsveld PP. “The effects of B-sitosterol (BSS) and B-sitosterol glucoside (BSSG) mixture on selected immune parameters of marathon runners: inhibition of post marathon immune suppression and inflammation.” Int-J-Sports-Med. 1999; 20(4): 258-62.

29. Bohn JA, BeMiller JN. “(1B>3)-b-D-Glucan as biological response modifiers: a review of structure ­functional activity relationships.” Carbohydrate Polymers 1995; 28: 3-14.

30. Bowles AP Jr., Perkins F. “Long-term remission of malignant brain tumors after intracranial infection: a report of four cases.” Neurosurgery. 1999; Mar. 44(3): 636-42 discussion 642-3.

31. Bisignano G, Tomaino A, et al. “On the in-vitro antimicrobial activity of oleuropein and hydroxytyrosol” J Pharm Pharmacol 1999; 51(Cool: 971-4.

32. Carroll MC, Prodeus AP. “Linkages of innate and adaptive immunity.” Curr Opin Immunol. 1998; 10(1): 36-40

33. Canss R, Limmer A, Sacher T, Arnold B, Hemmerhing CJ. “Autoaggression and tumor rejection: it takes more than self-specific T-cell acti­vation.” Immunol Rev. 1999; 169: 263-72.

34. Caruso D, Berra B, et al. “Effect of virgin olive oil phenolic compounds on in vitro oxidation of human low density lipoproteins.” Nutr Metab Cardiovasc Dis 1999; 9(3): 102-7.

35. Chen JR, Yen JH, Lin CC, Tsai WJ, Uiu WJ, Tsai JJ, Uin SF, Liu HW. “The effects of Chinese herbs on improving survival and inhibiting anti-ds DNA antibody production in lupus mice.” Am J Chin Med, 1993; 21(3-4): 257-62.

36. Chang R. “Functional properties of edible mushrooms.” Nutr Rev. 1996; 54(11 Pt 2): S91-3

37. Casadevall A, Scharff MD. “Return to the past: the case for antibody-based therapies in infectious

38. Chen CZ, Chen CL, Sun T, Hsieh CC, Henshall JM. “Effects of Cordyceps sinensis on murine T lymphocyte subsets.” Chin Med J (Engl). 1991; 104(1): 4-8.

39. Chiu JH; Jo CH; Wu LH; Lui WY; Wu CW; Shiao MS; Hong CY. “Cordyceps sinensis increases the expression of major histocompatibility com­plex class II antigens on human hepatoma cell line HA22T/VCH cells.” Am J Chin Med, 1998; 26(2): 159-70.

40. Chen YJ, Shiao MS, Lee SS, Wang SY. “Effect of Cordyceps sinensis on the proliferation and differentiation of human leukemic U937 cells.” Life Sci, 1997; 60(25): 2349-59.

41. Cheng Q. “Effect of cordyceps sinensis on cellular immunity in rats with chronic renal insufficiency.” Chung Hua I Hsueh Tsa Chih (Taipei), 1992; 72(1): 27-9; 63.

42. Chen CZ, Chen CL, Sun T, Hsieh CC, Henshall JM. “Effects of Cordyceps sinensis on murine T lymphocyte subsets.” Chin Med J (Engl). 1991; 104(1): 4-8.

43. Chinnah AD, Baig MA, Tizard IR, Kemp MC. “Antigen dependent adjuvant activity of a polydispersed heta-(1,4)-linked acetylated mannan (acemannan).” Vaccine. 1992, 10(Cool: 551-7

44. Chiu JH; Jo CH; Wu LH; Lui WY; Wu CW; Shiao MS; Hong CY. “Cordyceps sinensis increases the expression of major histocompatibility com­plex class II antigens on human hepatoma cell line HA22T/VCH cells.” Am J Chin Med, 1998; 26(2): 159-70

45. Colaco C. “Acquired wisdom in innate immunity.” Immunol Today. 1998; Jan 19(1): 5O.

46. Fearon DT. “Seeking wisdom in innate immunity.” Nature. 1997; 388:6640.

47. Coto JA, Hadden EM, Sauro M, Zorn N, Hadden JW. “Interleukin 1 regulates secretion of zinc-thymulin by human thymic epithelial cells and its action on T-lymphocyte proliferation and nuclear protein kinase C.” Proc Natl Acad Sci USA. 1992; 89(16): 7752-6.

48. Cordero-Miranda MA, Serrano-Miranda E, Flores-Sandoval C, Comez-Veta J, Orea-S M, Correa-Meza B, Ramirez R, Badillo-Flores A, Estrada-Parra S. “Treatment of Atopic Dermatitis with Transfer Factor and Cyclosporin A.” XIth international Congress on Transfer Factor, 1-4 MAR 1999, Monterrey, Mexico

49. Coni E, Di Benedetto R, et al. “Protective effect of oleuropein, an olive oil biophenol, on low density lipoprotein oxidizability in rabbits.” Lipids 1999; 35(1): 45-54.

50. Davis MK. “Review of the evidence for an association between infant feeding and child­hood cancer.” IntJ Cancer Sup p1, 1998; 11: 29-33

51. De Gucht V, Fischler B, Demanet C. “Immune dysfunction associated with chronic professional stress in nurses.” Psychiatry Res. 1999; 85(1): l05-11

52. Datsenko ZM, Volkov GL, et al. “Lipid composition and activity of certain enzymes in membranes of intestin al epithelium microvilli in rats with experimental hypercholesterinemia].” Ukr Biokhim Zh 1981; 53(4): 74-9.

53. Dellinger EP Babineau TJ, Bleieher P, Kaiser AB, Seibert GB, Postier RC, Vogel SB, Norman J, Kaufman D, Calandiuk S, Condon RE. “Effect of PGC-glucan on the rate of serious postoperative infection or death observed after high-risk gastrointestinal operations.” Betafectin Gastrointestinal Study Group. Arch Surg. 1999; 134(9) 977-83.

54. Deiana M, Aruoma OI, Bianchi ML, Spencer JP, Kaur H, Halliwell B, Aeschbach R, Banni S, Dessi MA, Corongiu FP. “Inhibition of peroxynitrite dependent DNA base modification and tyrosine nitration by the extra virgin olive oil-derived antioxidant hydroxytyrosol.” Free Radic Biol Med 1999, 26(5-6):762-9

55. .De Stefani E, Boffetta P, Ronco AL, Brennan P, Deneo-Pellegrini H, Carzoglio JC, Mendilaharsu M. “Plant sterols and risk of stomach cancer: a case-control study in Uruguay.” Nutr Cancer 2000;37(2):140-4.

56. De Stefani E, Brennan P, Boffetta P, Ronco AL, Mendilaharsu M, Deneo-Pellegrini H. “Vegetables, fruits, related dietary antioxidants, and risk of squamous cell carcinoma of the esophagus: a case-control study in Uruguay.” Nutr Cancer 2000;38(1):23-9.

57. De la Puerta R, Ruiz Gutierrez V, Hoult JR. “Inhibition of leukocyte 5-lipoxygenase by phenolics from virgin olive oil.” Biochem Pharmacol 1999; 57(4):445-9.

58. De la Puerta R, Martinez-Dominguez E, Ruiz-Gutierrez V. “Effect of minor components of virgin olive oil on topical anti-inflammatory assays.” Z Naturforsch [C] 2000; 55(9-10):814-9.

59. Donald PR, Lamprecht JH, Freestone M, Albrecht CF, Bouic PJ, Kotze D, van Jaarsveld PP. “A randomised placebo-controlled trial of the efficacy of beta-sitosterol and its glucoside as adjuvants in the treatment of pulmonary tuberculosis.” Int J Tuberc Lung Dis 1997;1(6):518-22. COMMENT IN: Int J Tuberc Lung Dis. 1998 Jun;2(6):522-3.

60. Diller IC, Mankowski ZT, Fisher ME. “The effects of yeast polysaccharides on mouse tumors.” Cancer Res. 1963, 23:201.

61. Ebina, T, Fujimiya Y “Antitumor effect of a peptide-glucan preparation extracted from Agaricus blazei in a double-grafted tumor system in mice.” Biotherapy 1998; 11(4): 259-65

62. Ebrahimzadeh H, Niknam VV, Maassoumi AA. “The sterols of Astragalus species from Iran: GLC separation and quantification.” Biochem Syst Ecol 2001; 29(4):393-404

63. .Egger SF, Brown CS, Kelsey US, Yates KM, Rosenberg U, Talmadge JE. “Hematopoietic augmentation by a beta-(1,4)-linked mannan. Cancer Immunol Immunother. 1996, 43(4), 195-205.

64. Fleming HP, Walter WM Jr., et al. “Antimicrobial properties of oleuropein and products of its hydrolysis from green olives.” Appl Microbiol 1973; 26(5): 777-82.

65. Enciso JA, Miranda ES, Comez-Martinez IC, Portuguez-Diaz A, Badillo A, Orea-S M, Comez-Vera J, Flores-Sandoval C, Estrada-Parra S. “Cytokine and Lymphocyte Levels in Extrinsic Asthma Patients Treated with Transfer Factor.” Xith International Congress on Transfer Factor, 1—4 MAR 1999, Monterrey, Mexico.

66. Elliott GA, Buthala DA, DeYoung EN. “Preliminary safety studies with calcium elenolate, an antiviral agent.” Antimicrob Agents Chemother. 1969; 9(-HD-):173-6

67. .Estrada A; Yun C-H; Van Kessel A; Li B; Hauta S; Uaarveld B. “Immunoregulatory Activities of Oat b-Clucan In vitro and In vivo.” Microbial Immunol 1997; 41(12): 991-998

68. Fabris N, Mocchegiani E, Calli M, Irato L, Lazzarin A, Moroni M. “AIDS, zinc deficiency, and thymic hormone failure.” JAMA. 1988 Feb 12; 259(6): 839-40.

69. Fabris N, Carzetti CC. “Role of zinc and alpha2 macroglobulin on thymic endocrine activity and on peripheral immune efficiency (Natural Killer activity and interleukin 2) in cervi­cal carcinoma.” BrJ Cancer 1999; 79: 244-50.

70. Fogleman RW, Shellenberger TF, Balmer ME, Carpenter RH, McAnalley BH. “Subchronic oral administration of acemannan in the rat and dog.” Vet Hum Toxicol. 1992, 34(2): 144-7.

71. Fogleman RW, Chapdelaine JM, Carpenter RH, McAnalley BH. “Toxicologic evaluation of injectable acemannan in the mouse, rat and dog.” Vet Hum Toxicol. 1992, 34(3), 20 1-5

72. .Feizi T. “Carbohydrate recognition systems in innate immunity.” Adv Exp Med Biol, 1998; 435: 51-54.

73. Fudenberg HH, Pizza C. “Transfer factor 1 993: New frontiers.” Progress in Drug Res. 1994; 42: 309-400

74. .Fudenberg HH. “Transfer Factor: Past, Present and Future.” Ann Rev Pharm Tox 1989; 475-516.

75. Fujimiya, Y, Suzuki Y, et al. “Tumor-specific cytocidal and immunopotentiating effects of relatively low molecular weight products derived from the basidiomycete, Agaricus blazei Murill.” Anticancer Res 1999; 19(1A): 113-8.

76. Fujimiya, Y, Suzuki Y, et al. “Selective tumoricidal effect of soluble proteoglucan extracted from the basidiomycete, Agaricus blazei Murill, mediated via natural killer cell

77. Fudenberg HH, Pizza C. “Transfer factor 1993: New frontiers.” Progress in Drug Res. 1994; 42: 309-400

78. Fortes C, Forastiere F, Agabiti N, Fano V, Pacifici R, Virgili F, Piras C, Guidi L, Bartoloni C, Tricerri A, Zuccaro P, Ebrahim S, Perucci CA. “The effect of zinc and vitamin A supplementation on immune response in an older population.” J Am Geriatr Soc 1998; 46: 19-26.

79. Graybill JR, Bocanegra R, Najvar LK, Loebenberg D, Luther MF. “Granulocyte colony_stimulating factor and azole antifungal therapy in murine aspergillosis: role of immune suppression.” Antimicrob Agents Chemother. 1998, 42(10):2467-73.

80. Goldman RC. “Biological Response Modification by b-D-Clucans.” Ann Reports Med Chem. 1995; 30: 129-138.

81. Gylling H, Puska P, et al. “Serum sterols during stanol ester feeding in a mildly hypercholesterolemic population.” J Lipid Res 1999; 40(4): 593-600.

82. Hadden JW, Malec PH, Coto J, Hadden EM. “Thymic involution in aging. Prospects for correction.” Ann NY Acad Sci. 1992; 673(23): 1-9.

83. Halford WP, Veress LA, Cebhardt BM, Carr DJ. “Innate and acquired immunity to herpes simplex virus type 1.” Virology, 1997; 236(2): 328-37.

84. Hanson LA. “Breastfeeding Stimulates the Infant Immune System.” Science and Medicine. 1997; 2-11

85. Hana I, Stara J, Boguszakova J, Pekarek J, Ivaskova F. “Transfer Factor (Immodin Sevac) Treatment of Recurrent Anterior Uveitis B a Retrospective Evaluation after Ten Years.” XIth International Congress on Transfer Factor, 1-4 MAR 1999, Montertey, Mexico

86. Harris C, Pierce K, King C, Yates KM, Hall J, Tizard I. “Efficacy of acemannan in treatment of canine and feline spontaneous neo­plasms.” Mol Biother. 1991, 3(4), 207-13.

87. Hess C, Steiger JU, Schifferhi JA. “Complement and its role in immune response.” Schweiz Med Wochenschr. 1998; 128(11): 393-9

88. Hirschman SZ. “Inactivation of DNA polymerases of murine leukaemia viruses by calcium elenolate.” Nat New Biol 1972; 238(87):277-9.

89. Hishida I; Nanba H; Kuroda H. “Antitumor activity exhibited by orally administered extract from fruit body of Grifola frondosa (maitake).” Chem Pharm Bull (Tokyo). 1988; 36(5): 1819-27

90. Hoffman OA, Olson EJ, Limper AH. “Fungal beta-glucans modulate macrophage release of tumor necrosis fac­tor-alpha in response to bacterial lipopolysaccharide.” Immunol Lett, 1993; 37(1): 19-25.

91. Huang C; Ma WY; Hecht SS; Dong Z. “Inositol hexaphosphate inhibits cell transformation and activator protein 1 activation by targeting phosphatidylinositol-3’ kinase.” Cancer Res, 1997, 57(14): 28 73-8

92. .Itoh H, Ito H, et al. “Inhibitory action of a (1-->6)-beta-D-glucan-protein complex (F III-2-b) isolated from Agaricus blazei Murill ("himematsutake") on Meth A fibrosarcoma-bearing mice and its antitumor mechanism.” Jpn J Pharmacol 1994; 66(2): 265-71

93. .Ito H, Shimura K, et al. “Antitumor effects of a new polysaccharide-protein complex (ATOM) prepared from Agaricus blazei (Iwade strain 101) "Himematsutake" and its mechanisms in tumor-bearing mice.” Anticancer Res 1997; 17(1A): 277-84

94. .Juven B, Henis Y, et al. “Studies on the mechanism of the antimicrobial action of oleuropein. J Appl Bacteriol 1972; 35(4): 559-67.Petkov V, Manolov P.

95. Janeway CA. “The road less traveled by: the role of innate immunity in the adaptive immune response. Presidential Address to The American Association of Immunologists. Jr. J Immunol, 1998; 161(2): 53 4.

96. Jong SC, Birmingham JM. “Medicinal and therapeutic value of the shiitake mushroom.” Adv Appl Microbiol, 1993; 39: 153-84.

97. Jones JF, et al. “Oral bovine Transfer Factor (OTF) use in the hyper-IgE syndrome.” Immunobiology of Transfer Factor. Academic Press: New York. 1983, pp 26 1-70

98. Kahlon JB, Kemp MC, Yawei N, Carpenter RH, Shannon WM, McAnalley BH. “In vitro evaluation of the synergistic antiviral effects of acemannan in com­bination with azidothymidine and acyclovir.” Mol Biother. 1991, 3(4), 214-23.

99. Kimball JW. Introduction to Immunology. Macmillan Publishing co., Inc.; New York 1983: 275

100. Kiechl S, Egger G, Mayr M, Wiedermann CJ, Bonora E, Oberhollenzer F, Muggeo M, Xu Q, Wick G, Poewe W, Willeit J. “Chronic infections and the risk of carotid atherosclerosis: prospective results from a large population study.” Circulation 2001; Feb. 27; 103(Cool: 1064-70

101. Kos FJ “Regulation of adaptive immunity by Natural Killer cells.” Immunol Res, 1998; 17(3): 303-12

102. Kuo YC, Tsai WJ, Shiao MS, Chen CE, Lin CY. “Cordyceps sinensis as an immunomodulatory agent.” Am J Chin Med. 1999; 24(2): 111-25.

103. Hauser CJ, Joshi P, Jones Q, Zhou X, Livingston DH, Lavery RE. “Suppression of Natural Killer cell activity in patients with fracture/soft tissue injury. “ Arch Surg. 1997; 132(12): 1326-30

104. Hertzler SR, et al. J Am Diet Assoc 1996; 96: 243-6

105. “Inhibition of leukocyte leukotriene B4 production by an olive oil-derived phenol identified by mass-spectrometry.” Petroni A, Blasevich M, Papini N, Salami M, Sala A, Galli C. Thromb Res 1997, 87(3):315-22.

106. Kawagishi, H., R. Inagaki, et al. “Fractionation and antitumor activity of the water-insoluble residue of Agaricus blazei fruiting bodies.” Carbohydr Res 1989, 186(2): 267-73

107. King GK, Yates KM, Greenlee PC, Pierce KR, Ford CR, McAnalley BH, Tizard JR. “The effect of Acemannan Immunostimulant in combination with surgery and radiation therapy on spontaneous canine and feline fibrosarcomas.” J Am Anim Hosp Assoc. 1995, 31(5): 439-47.

108. Kirkpatrick CH. “Structural Nature and Functions of Transfer-Factors.” Annals of The New York Academy of Sciences 1993, 685, 362-368.

109. Kirkpatrick CH. “Peptide Sequences That Are Common to Transfer Factors.” XIth International Congress on Transfer Factor, 1-4 MAR 1999, Monterrey, Mexico.

110. Kirkpatrick CH. “Activities and characteristics of Transfer Factors.” Biotherapy 1996; 9(1-3): 13-6

111. Kirkpatrick C H, Hamad AR, Morton LC. “Murine Transfer Factors: dose-response relationships and routes of administration.” Cell Immunol 1995; 164(2): 203-6.

112. Kiprono PC, Kaberia F, Keriko JM, Karanja JN. “The in vitro anti-fungal and anti-bacterial activities of beta-sistosterol from Senecio lyratus (Asteraceae).” Z Naturforsch [C] 2000; 55(5-6):485-8.

113. Kramer ED, Packer RJ, Ginsberg J, Goldman S, Thompson S, Bayer LA, Shen V, Harris R, Khan S, Finlay JL. “Acute neurologic dysfunction associated with high-dose chemotherapy and autologous bone marrow rescue for primary malignant brain tumors.” Pediatr Neurosurg, 1997; 27(5): 230-7.

114. Klobasa F, Habe F, Werhahn F. “The absorption of colostral immunoglobulins in newborn piglets. II. Effect of water or glucose solutions on the permeability of the newborn intestine” Ben Munch Tierarztl Wochenschr 1991; 104: 37-41.

115. Kohyama N, Nagata T, et al. “Inhibition of arachidonate lipoxygenase activities by 2-(3,4-dihydroxyphenyl) ethanol, a phenolic compound from olives.” Biosci Biotechnol Biochem 1997; 61(2): 347-50.

116. Kobayashi Y, Sugaya Y, et al. “Clinical effects of beta-sitosterol (phytosterol) on benign prostatic hype rplasia: preliminary study.” Hinyokika Kiyo 1998, 44(12): 865-8.

117. Klippel KF, Hiltl DM, et al. “A multicentric, placebo-controlled, double-blind clinical trial of beta-sit osterol (phytosterol) for the treatment of benign prostatic hyperplasia. German BPH-Phyto Study group.” Br J Urol 1997, 80(3): 427-32.

118. Lachmann PJ, Davies A. “Complement and immunity to viruses.” Immunological Reviews. 1997; 159: 69-77

119. .Lawerence HS. “The cellular transfer of cutaneous hypersensitivity to tuberculin in man.” Proc Soc Exp Biol Med 1949; 71: 516

120. .Lawrence HS, Borkowsky W. “A new basis for the immunoregulatory activities of transfer factor—an arcane dialect in the language of cells.” Cell Immunol. 1983; 82: 102-16.

121. Lonnerdal B, Iyer S. “Lactoferrin: Molecular Structure and Biological Function.” Annual Reviews in Nutrition 1995; 15: 93-110

122. .Lawrence HS, Borkowsky W. “Transfer Factor current status and future prospects.” Biotherapy 1996, 9(1-3), i-S.

123. Levine PH, Whiteside TL, Friherg D, Bryant J, Colclough C, Herberman RB. “Dysfunction of Natural Killer activity in a family with chronic fatigue syn­drome.” Clin Immunol Immunopathol. 1998; 88(1): 96-104.

124. Levy SB. “Antibiotic resistance: an ecological imbalance.” Ciba Found Symp. 1997; 207(1-9): 1-9 discussion 9-14

125. .Li US. Zheng F. Liu ZH. “Experimental study on effect of Cordyceps sinensis in ameliorating amino­glycoside induced nephrotoxicity.” Chung Kuo Chung Hsi I Chieh Ho Tsa Chih. 1996; Dec. 16(12): 733-7.

126. Lira P1, Ashworth A, Morris SS. “Effect of zinc supplementation on the morbidity, immune function, and growth of low-birth-weight, full-term infants in northeast Brazil.” Am J Clin Nutr 1998; 68: 418S-424S.

127. Liu P, Zhu I, Huang Y, Liu C. “Influence of Cordyceps sinensis (Berk.) Sacc. and rat serum containing same medicine on IL-i, lEN and TNF produced by rat Kupffer cells” Chung Kuo Chung Yao Tsa Chih. 1996; 21(6): 367-9, 384.

128. Liu C, Lu S, Ji MR. “Effects of Cordyceps sinensis (CS) on in vitro Natural Killer cells.” Chung Kuo Chung Hsi I Chieh Ho Tsa Chih. 1992; 12(5): 267-9, 259

129. .Li US. Zheng F. Liu ZH. “Experimental study on effect of Cordyceps sinensis in ameliorating amino­glycoside induced nephrotoxicity.” Chung Kuo Chung Hsi I Chieh Ho Tsa Chih. 1996; Dec. 16(12): 733-7.

130. Ling WH, Jones PJ. “Dietary phytosterols: a review of metabolism, benefits and side effects” Life Sci 1995; 57(3):195-206.

131. Lissoni P; Ciani U; Zerbini S; Trabattoni P; Rovelli E. “Biotherapy with the pineal immunomodulating hormone melatonin versus melatonin plus aloe vera in untreatable advanced solid neoplasms.” Nat Immun. 1998, 16:1: 27-33.

132. Matzinger P. “An innate sense of danger.” Semin Immunol, 1998; 10:5: 399-4 15

133. .Manna C, Della Ragione F, Cucciolla V, Borriello A, D'Angelo S, Galletti P, Zappia V. “Biological effects of hydroxytyrosol, a polyphenol from olive oil endowed with antioxidant activity.” Adv Exp Med Biol 1999, 472(-HD-):115-30.

134. Manna C, Galletti P, Maisto G, Cucciolla V, D'Angelo S, Zappia V. “Transport mechanism and metabolism of olive oil hydroxytyrosol in Caco-2 cells.” FEBS Lett 2000; 470(3):341-4.

135. Manahe N, Sugimoto M, Azuma Y, Taketomo N, Yamashita A, Tsuboi H, Tsunoo A, Kinjo N, Nian Lai H, Miyamoto H. “Effects of the mycelial extract of cultured Cordyceps sinensis on in vivo hepatic energy metabolism in the mouse.” Jpn J Pharmaco. 1996; Jan, 70(1): 85-8.

136. Medzhitov R, Janeway CA. “Innate immune recognition and control of adaptive immune responses.” Jr Semin lmmunol, 1998; 10(5): 351-3.

137. Medzhitov R, Janeway CA. “An ancient system of host defense.” Jr Curr Opin Immunol, 1998; 10(1): 12-5.

138. Medzhitov R, Janeway CA. “Innate immune recognition and control of adaptive immune responses.” Jr Semin lmmunol, 1998; 10(5): 351-3.

139. Messina M, Barnes S. “The role of soy products in reducing risk of cancer.” J Natl Cancer Inst 1991; 83(Cool:541-6.

140. Mocchegiani F, Santarelli L, Muzzioli M, Fabris N. “Reversibility of the thymic involution and of age-related peripheral immune dysfunctions by zinc supplementation in old mice.” IntJ Immunopharmacol. 1995; 17(9): 703-18

141. .Mocchegiani F, Bulian D, Santarelli L, Tibaldi A, Muzzioli M, Lesnikov V, Pierpaoli W, Fabris N. “The zinc poo1 is involved in the immune-reconstituting effect of melatonin in pinealectomized mice.” J Pharmacol Fxp Then. 1996; 277:1200-8.

142. Mocchegiani F, Ciavattini A, Santarelli L, Tibaldi A, Muzzioli M, Bonazzi P, Ciacconi

143. Montecino-Rodriguez E, Dorshkind K. “Thymocyte development in vitro: implications for studies of ageing and thymic involution.” Mech Ageing Dee. 1997; 93(1-3): 47-57.

144. Montaner JS, Gill J, Singer J, Rahoud I, Arseneau R, McLean BD, Schechter MT, Ruedy J. “Double-blind placebo-controlled pilot trial of acemannan in advanced human immunodeficiency virus disease.” J Acquir Immune Defic Syndr Hum Retrovirol. 1996, 12(2): 153-7

145. .Monograph: “Plant sterols and sterolins.” Altern Med Rev 2001; 6(2):203-6.

146. Milone MC, Fitzgerald Bocarsly P. “The mannose receptor mediates induction of IFN-alpha in peripheral blood dendritic cells by enveloped RNA and DNA viruses.” J Immunol, 1998; 161(5): 2391-9

147. .Mizuno, M, Minato K, et al. “Anti-tumor polysaccharide from the mycelium of liquid-cultured Agaricus blazei mill.” Biochem Mol Biol Int 1999, 47(4): 707-14

148. .Navarro-Cruz D, Serrano-Miranda E, Orea-S M, Estrada-Parra S, Teran-Ortiz L, Comez-Vera J, Flores-Sandoval C. “Transfer Factor as a Good Therapeutic Agent in Moderate and Severe Atopic Dermatitis.” XIth International Congress on Transfer Factor. 1-4 MAR 1999, Monterrey, Mexico.

149. Nanba H. “Activity of maitake D-fraction to inhibit carcinogenesis and metastasis.” Ann N Y Acad Sci, 1995, 768: 243-5

150. .Nanha H; Kubo K. “Effect of Maitake D-fraction on cancer prevention.” Ann N Y Acad Sci, 1997; 833: 204-7.

151. Nanha H; Kuroda H. “Antitumor mechanisms of orally administered shiitake fruit bodies.” Chem Pharm Bull (Tokyo). 1987; 35(6): 2459-64

152. .Nanba H, Mon K, Toyomasu T, Kuroda H. “The action of shiitake (Lentinus edodes) fruit bodies orally administered to mice.” Chem Pharm Bull (Tokyo). 1987; 35(6): 2453-8.

153. Nanba H, Hamaguchi A, Kuroda H. “The chemical structure of an antitumor polysaccharide in fruit bodies of Crifola frondosa (maitake).” Chem Pharm Bull (Tokyo), 1987; 35(3): 1162-8.

154. Navarro A, De las Heras B, Villar A. “Anti-inflammatory and immunomodulating properties of a sterol fraction from Sideritis foetens Clem.” Biol Pharm Bull 2001; 24(5):470-3.

155. Nguyen LB, Shefer S, Salen G, Tint GS, Ruiz F, Bullock J. “Mechanisms for cholesterol homeostasis in rat jejunal mucosa: effects of cholesterol, sitosterol, and lovastatin.” J Lipid Res 2001; 42(2):195-200.

156. Sakamoto K; Venkatraman C; Shamsuddin. “Growth inhibition and differentiation of HT-29 cells in vitro by inositol hexa­phosphate (phytic acid).” Carcinogenesis, 1993, 14(9): 1815-9.

157. Shamsuddin AM; Yang GY; Vucenik I. “Novel anti-cancer functions of IP6: growth inhibition and differentiation of human mammary cancer cell lines in vitro.” Anticancer Res, 1996, 16:6A, 3287-92.

158. Shamsuddin AM. “Reduction of cell proliferation and enhancement of NK-cell activity.” United States Patent 5,082,833; Jan 21, 1992.

159. Shamsuddin AM. “Inositol phosphates have novel anticancer function.” J Nutr, 1995, 125:3 Suppl, 725S-732S.

160. Suzuki I; Tanaka H; Kinoshita A; Oikawa S; Osawa M; Yadomae T. “Effect of orally administered beta-glucan on macrophage function in mice. J Immunopharmacol. 1990; 12(6): 675-84.

161. Tassou CC, Nychas GJ, et al. “Effect of phenolic compounds and oleuropein on the germination of Bacillus cereus T spores.” Biotechnol Appl Biochem 1991; 31 (2): 231-7.

162. Ondarza R, Chavez R, Serrano E, Correa B, Ramirez R, Estrada-C 1, Estrada-Parra S. “Successful Treatment of Neuritis Posherpetca (Caused by Herpes Zoster) with Specific Transfer Factor.” XIth International Congress on Transfer Factor, 1-4 MAR 1999, Monterrey, Mexico

163. Onderdonk AB, Cisneros RU, Hinkson P, Ostroff C. “Anti-infective effect of poly-beta 1-6-glucotriosyl-beta 1-3-glucopyranose glucan in vivo.” In feet Immun, 1992; 60(4): 1642-7.

164. Ojo Amaize EA, Conley EJ, Peter JB. “Decreased Natural Killer cell activity is associated with severity of chronic fatigue immune dysfunction syndrome.” Clin infect Dis. 1994; 18 Suppl 1: S157-9.

165. Owen RW, Mier W, Giacosa A, Hull WE, Spiegelhalder B, Bartsch H. “Phenolic compounds and squalene in olive oils: the concentration and antioxidant potential of total phenols, simple phenols, secoiridoids, lignansand squalene.” Food Chem Toxicol 2000, 38(Cool: 647-59

166. Owen RW, Giacosa A, Hull WE, Haubner R, Spiegelhalder B, Bartsch H. “The antioxidant/anticancer potential of phenolic compounds isolated from olive oil.” Eur J Cancer 2000; 36(10):1235-47

167. Page CC, Ben Eliyahu S. “A role for NK cells in greater susceptibility of young rats to metastatic forma­tion.” Dcv Comp Immunol. 1999; 23(1): 87-96

168. .Padmaja V, Thankamany V, Hisham A. “Antibacterial, antifungal and anthelmintic activities of root barks of Uvaria hookeri and Uvaria narum.” J Ethnopharmacol. 1993; 40(3):181-6.

169. Park E, Kahng J, Lee SH, Shin K. “An anti-inflammatory principle from cactus.” Fitoterapia 2001;72(3):288-90.

170. Petschow BW, Talhott RD. “Reduction in virus-neutralizing activity of a bovine colostrum immunoglob­ulin concentrate by gastric acid and digestive enzymes.” J Pediatr Gastroenterol Nutr. 1994; 19: 228-35.

171. Pollak OJ, Kritchevsky D. “Monographs in Atherosclerosis.” New York: Basel (1981).

172. Phytosterols.” Crit Rev Food Sci Nutr 1999, 39(3): 275-283

173. Pizza C, Visa D, Boucheix CI, Corrado E. “Effect of in vitro produced transfer factor on the immune response of cancer patients.” Fur J Cancer. 1977; 13: 917-23.

174. Pizza C, Viza D. “Transfer Factor in the Era of AIDS.” Biotherapy 1996; 9(1-3): ix-x.

175. Pizza C, De Vinci C, Fornarola V, Palareti A, Baricordi 0, Viza D. “In vitro studies during long-term oral administration of specific Transfer Factor.” Biotherapy 1996; 9(1-3): 175-85.

176. Pizza C, De Vinci C, Palareti A, Viza D. “Twenty-five Years of Clinical Experience with Transfer Factor.” XIth International Congress on Transfer Factor, 1-4 MAR 1999, Monterrey, Mexico.

177. Pizza C., De Vinci C., Fudenberg HH. “Transfer factor in Malignancy.” Progress in Drug Res. 1994; 42: 401-421.

178. Petkov V, Manolov P. “Pharmacological analysis of the iridoid oleuropein.” Arzneimittelforschung 1972; 22(9): 1476-86.

179. Pizza C, De Vinci C, Palareti A, Viza D. “Twenty-five Years of Clinical Experience with Transfer Factor.” XIth International Congress on Transfer Factor, 1-4 MAR 1999, Monterrey, Mexico.

180. “Pharmacological analysis of the iridoid oleuropein.” Arzneimittelforschung 1972; 22(9): 1476-86.

181. “Phytotherapy in treatment of benign prostatic hyperplasia: a critical review.” Lowe FC, Ku JC. Urology 1996; 48(1): 12-20.

182. Ramamoorthy U, Kemp MC, Tizard JR. “Acemannan, a beta-(1,4)-acetylated mannan, induces nitric oxide production in macrophage cell line RAW 264.7.” Mol Pharmacol. 1996; 50(4): 878-84.

183. Raicht RF, Cohen BI, Fazzini EP, Sarwal AN, Takahashi M. “Protective effect of plant sterols against chemically induced colon tumors in rats.” Cancer Res 1980; 40(2):403-5.

184. Rao AV, Janezic SA. “The role of dietary phytosterols in colon carcinogenesis.” Nutr Cancer. 1992; 18(1):43-52.

185. Renis HE. “Influenza virus infection of hamsters. A model for evaluating antiviral drugs” Arch Virol 1977, 54(1-2):85-93

186. .Renis HE. “In vitro antiviral activity of calcium elenolate.” Antimicrob Agents Chemother 1969; 9(-HD-):167-72.

187. Riodan JM. “The cost of not breastfeeding: a commentary.” J Hum Lact. 1997; 13(2): 93-7.

188. Roitt I, Brostoff J, Male D. Immunology. Fourth Ed. Moshy, London, 1996

189. .Roda F, Viza D, Pizza C, Mastroroberto L, Phillips J, De Vinci C, Barbara L. “Transfer factor for the treatment of HbsAg-positive chronic active hepatitis.” Proc Soc Exp Med. 1985; 178: 468-75.

190. Ross CD, Vetvicka V, Yan J, Xia Y, Vetvickova J. “Therapeutic intervention with complement and beta-glucan in cancer.” Immunopharmacology. 1999, 42(1-3): 61-74.

191. Rose NR. “Thymus function, ageing and autoimmunity.” Immunol Lett. 1994;

40(3): 225-30

192. Roberts PR, Burney JD, Black KW, Zaloga CP. “Effect of chain length on absorption of biologically active peptides from the gastrointestinal tract.” Digestion 1999; 60: 332-7.

193. Roberts DB, Travis EU. “Acemannan-containing wound dressing gel reduces radiation-induced skin reactions in C3H mice.” Int J Radiat Oncol Biol Phys. 1995, 32(4): 1047-52

194. Rump JA, Arndt R, Arnold A, Bendick C, Dichtelmuller H, Franke M, Helm EB, hager H, Kampmann B, Kolb P, et al. “Treatment of diarrhoea in human immunodeficiency virus-infected patients with immunoglobulins from bovine colostrum.” Clin Investig 1992; 70: 588-94.

195. Sakamoto M, Fujisawa Y, Nishioka K. “Physiologic role of the complement system in host defense, disease, and mal­nutrition.” Nutrition. 1998; 14(4): 391-8.

196. Salami M, Galli C, De Angelis L, Visioli F. “Formation of F2-isoprostanes in oxidized low density lipoprotein: inhibitory effect of hydroxytyrosol.” Pharmacol Res 1995 , 31(5):275-9.

197. Saied IT; Shamsuddin AM. “Up-regulation of the tumor suppressor gene p53 and WAF1 gene expression by 1P6 in HT-29 human colon carcinoma cell line.” Anticancer Res, 1998, 18:3A, 1479-84

198. Scharton Kersten TM, Sher A. “Role of Natural Killer cells in innate resistance to protozoan infections.” Curr Opin Immunol. 1997; 9(1): 44-51

199. Scow HF “Pathogen interactions with cytokines and host defense: an overview.” Vet Immunol Immunopathol, 1998; May, 63(1-2): 139-48.

200. See DM, Roshan R. Enhancement of Natural Killer (NK) cell Activity by Natural Products. Institute of Longevity Medicine. In press

201. Sergio CC. “Experience with Transfer Factor with 60 Patients in ICU.” XIth International Congress on Transfer Factor, 1—4 MAR 1999, Monterrey, Mexico

202. See DM, Khemka P, Sahl L, Bui T, Tilles JG. “The role of Natural Killer cells in viral infections.” ScandJ Immunol. 1997; 46(3): 217-24

203. See D, Curnee K, UeClair M. “An In Vitro Screening Study of 196 Natural Products for Toxicity and Efficacy.”. J Am Nutraceutical Assoc. 1999, 2(1), 25-4.

204. Shamsuddin AM; Vucenik I; Cole KE. “JP6: a novel anti-cancer agent.” Life Sci, 1997, 61:4, 343-54.

205. Shamsuddin AM. “Inositol phosphates have novel anticancer function.” I Nutr, 1995, 125:3 Suppl, 725S-732S.

206. Shamsuddin AM; Yang GY. “Inositol hexaphosphate inhibits growth and induces differentiation of PC-3 human prostate cancer cells.” Carcinogenesis, 1995; 16(Cool: 1975-9.

207. Shamsuddin AM; Flsayed AM; Ullah A. “Suppression of large intestinal cancer in F344 rats by inositol hexaphos­phate.” Carcinogenesis, 1988 Apr, 9(4): 577-80.

208. Soret MG. “Antiviral activity of calcium elenolate on parainfluenza infection of hamsters.” Antimicrob Agents Chemother 1969; 9(-HD-):160-6.

209. Shankar AH, Prasad AS. “Zinc and immune function: the biological basis of altered resistance to infec­tion.” Am J Clin Nutr 1998; 68:447S-463 S

210. Sharma JM, Karaca K, Pertile T. “Virus-induced immunosuppression in chickens.” Poult Sci. 1994, 73(7): 1082-6

211. .Steinmetz KA, Potter JD. “Vegetables, fruit, and cancer prevention: a review.” J Am Diet Assoc 1996 , 96(10):1027-39.

212. Suarez FL, et al. Aliment Pharmacol Ther 1995; 9: 589-97.

213. Solana R, Alonso MC. “Natural Killer cells in healthy aging.” Peta J Exp Gerontol. 1999; 34(3): 435-43.

214. Solomon GE, Segerstrom SC, Grohr P, Kemeny M, Fahey J. “Shaking up immunity: psychological and immunologic changes after a natural disaster” (see comments] Psychosom Med. 1997; 59(2): 114-27.

215. Sharon J. Basic Immunology. Baltimore: Williams and Wilkins, , 1998.

216. Shinkai S, Konishi M, Shephard RJ. “Aging and immune response to exercise.” Can J Physiol Pharmacol. 1998; 76(5): 562-7.

217. Sirtori CR, Manzoni C, Lovati MR. “Mechanisms of lipid-lowering agents.” Cardiology 1991; 78(3):226-35.

218. Sprietsma JE. “Zinc-contiolled Thl/Th2 switch significantly determines development of dis­eases.” Med-Hypotheses. 1997 Jul; 49(1): 1-14

219. Stuart RW, Lefkowitz DL, Lincoln JA, Howard K, Celderman MP, Lefkowitz SS. “Upregulation of phagocytosis and candidicidal activity of macrophages exposed to the immunostimulant acemannan.” Int J Immunopharmacol. 1997; 19(2): 75-82.

220. Tauxe RV. “Emerging Foodborne Diseases: An Evolving Public Health Challenge.” The National Conference on Emerging Foodborne Pathogens: Implications and Control, March 24-26m 1997, Alexandria, Virginia, USA Emerging Infectious Diseases. 1997; 3(4).

221. Talaro KP, Talaro A. Foundations in Microbiology, 3rd Ed., McGraw-Hill,1999.

222. Talaro KP, Talaro A. “Human Natural Killer cells.” Arch Immunol Ther Exp (Warsz). 1998; 46(4): 213-29.

223. Toyama Sorimachi N, Koyasu S. “Regulatory mechanisms of NK cell functions” Nippon Rinsho. 1999; 57(2): 304-9.

224. Tian J, Chen XM, Li US. “Effects of Cordyceps sinensis, rhubarb and serum renotropin on tubular epithelial cell growth.” Chung Hsi I Chieh Ho Tsa Chih. 1991; 11(9): 547-9, 518

225. “Transfer Factor in the Era of AIDS: The Proceedings of the Xth International Symposium on Transfer Factor, 22-24 June 1995, Bologna, Italy.” Biotherapy. 1996; 9(1-3): 1-185.

226. Transfer FactorTN~ is a trademark of 4Uife Research, Inc.; Sandy, UT

227. Tranter H S, Tassou SC, et al. “The effect of the olive phenolic compound, oleuropein, on growth and enterotoxin B production by Staphylococcus aureus.” J Appl Bacteriol 1993; 74(3): 253-9.

228. Usinger WR. “A comparison of antibody responses to veterinary vaccine antigens potenti­ated by different adjuvants.” Vaccine. 1997, 15(17-18), 1902-7

229. Vetvicka V, Hanikyrova M, Vetvickova J, Ross CD. “Regulation of CR3 (CD11b/CD18)-dependent Natural Killer (NK) cell cyto­toxicity by tumour target cell MHC class I molecules.” Clin Exp Immunol. 1999; 115(2): 229-35.

230. Vucenik I, Tantivejkul K, Zhang ZS, Cole KE, Saied I, Shamsuddin AM. “IP6 in treatment of liver cancer. I. IP6 inhibits growth and reverses trans­formed phenotype in HepC2 human liver cancer cell line.” Anticancer Res, l998; 1 8:6A: 4083-90.

231. Vucenik I; Zhang ZS; Shamsuddin AM. “IP6 in treatment of liver cancer. II. Jntra-tumoral injection of 1P6 regresses pre-existing human liver cancer xenotransplanted in nude mice.” Anticancer Res, 1998, 18:6A, 409 1-6.

232. Visioli F, Galli C. “Oleuropein protects low density lipoprotein from oxidation.” Life Sci 1994; 55(24): 1965-71.

233. Visioli F, Bellomo G, Galli C. “Oleuropein (ester of elenolic acid and 3,4-dihydroxy-phenylethanol (hydroxytyrosol)) Free radical-scavenging properties of olive oil polyphenols.” Biochem Biophys Res Commun. 1998, 247(1):60-4.

234. Vetvicka V, Thornton BP, Wieman TJ, Ross CD . “Targeting of Natural Killer cells to mammary carcinoma via naturally occur­ring tumor cell-bound iC3b and beta-glucan-primed CR3 (CD1Tb/CD1 Cool.” J Immunol, 1997; 159(2): 599-605. See ref 1-4.

235. Vetvicka V, Thornton BP, Wieman TJ, Ross CD . “Targeting of Natural Killer cells to mammary carcinoma via naturally occur­ring tumor cell-bound iC3b and beta-glucan-primed CR3 (CD1Tb/CD1 Cool.” J Immunol. 1997; 159(2): 599-605. See ref 6-8.

236. Velders MP, Schreiber H, Kast WM. “Active immunization against cancer cells: impediments and advances.” Semin Oncol. 1998; 25(6): 697-706

237. Vlietinck AJ, De-Bruyne T, Apers S, Pieters LA. “Plant-derived leading compounds for chemotherapy of human immunodefi­ciency virus (HIV) infection.” Planta Med. 1998, 64(2), 97-109.

238. Vucenik I; Yang CY; Shamsuddin AM. “Comparison of pure inositol hexaphosphate and high-bran diet in the pre­vention of DMBA-induced rat mammary carcinogenesis.” Nutr Cancer, 1997, 28:1, 7-13.

239. Vucenik I; Yang CY; Shamsuddin AM. “Inositol hexaphosphate and inositol inhibit DMBA-induced rat mammary cancer. Carcinogenesis, 1995, 16:5, 1055-8.

240. Vucenik I; Shamsuddin AM. “[3H]inositol hexaphosphate (phytic acid) is rapidly absorbed and metabo­lized by murine and human malignant cells in vitro.” J Nutr, 1994, 124:6, 86 1-8.

241. Vucenik I; Sakamoto K; Bansal M; Shamsuddin AM. “Inhibition of rat mammary carcinogenesis by inositol hexaphosphate (phytic acid). A pilot study.” Cancer Lett, 1993; Dec, 75(2): 95-102

242. Vucenik I, Tantivejkul K, Zhang ZS, Cole KE, Saied I, Shamsuddin AM. “IP6 in treatment of liver cancer. I. IP6 inhibits growth and reverses trans­formed phenotype in HepC2 human liver cancer cell line.” Anticancer Res, l998; 1 8:6A: 4083-90.

243. Vucenik I; Zhang ZS; Shamsuddin AM. “IP6 in treatment of liver cancer. II. Jntra-tumoral injection of 1P6 regresses pre-existing human liver cancer xenotransplanted in nude mice.” Anticancer Res, 1998, 18:6A, 409 1-6.

244. Viza D. “Aids and Transfer Factor: Myths, Certainties and Realities.” Biotherapy. 1996; 9(1-3): 17-26.

245. Vilmos P, Kurucz E. “Insect immunity: evolutionary roots of the mammalian innate immune sys­tem.” Immunol Lett, 1998; 62(2): 59-66.

246. Visioli F, Bellosta S, et al. “Oleuropein, the bitter principle of olives, enhances nitric oxide production by mouse macrophages.” Life Sci 1998; 62(6): 541-6.

247. Visioli F, Galli C, Bornet F, Mattei A, Patelli R, Galli G, Caruso D. “Olive oil phenolics are dose-dependently absorbed in humans.” FEBS Lett 2000; 468(2-3):159-60.

248. Walter W, Fleming Jr.HP, et al. “Preparation of antimicrobial compounds by hydrolysis of oleuropein from green olives.” Appl Microbiol 1973; 26(5): 773-6.

249. Wasser SP; Weis AL. “Therapeutic effects of substances occurring in higher Basidiomycetes mush­rooms: a modern perspective.” Crit Rev Immunol, 1999; 19(1): 65-96.

250. Wang yuying, Liu Zhenxiang, Shen Li. “TF, Psoriasis and Cytokines.” XIth International Congress on Transfer Factor, 1—4 MAR 1999, Monterrey, Mexico.

251. Wang Huifang, Zhou Cuanghua, Yu Zhiying, Xu Yonggang, Jiang Jia Kun. “Observation of 26 Senile Cases Treated with P-TFOL.” XIth International Congress on Transfer Factor, 1-4 MAR 1999, Monterrey, Mexico.

252. Wawrzynczak EJ.Antibody Therapy. Oxford, UK: BIOS Scientific Publishers Limited, 1995, p 9-10.

253. Wellinghausen N; Rink L. “The significance of zinc for leukocyte biology.” J Leukoc Biol, 1998; 64(5): 571-7.

254. Weihrauch JL, Gardner JM “Sterol content of foods of plant origin.” J Am Diet Assoc 1978; 73: 39-47

255. Wellinghausen N, Kirchner H, Rink L. “The immunobiology of zinc.” Immunol Today 1997; 18(11): 519-21

256. Weir DM, Stewart J. Immunology, 8th Ed. Churchill Livingstone, New York, 1997: 261

257. Weizel A, Richter WO. “Drug therapy of severe hypercholesterolemia.” Eur J Med Res 1997; 2(6):265-9.

258. Womble D, Helderman JH. “The impact of acemannan on the generation and function of cytotoxic T-lym­phocytes.” lmmunopharmacol Immunotoxicol.1992, 14(1-2): 63-77.

259. Woods JA, Davis JM, Smith JA, Nieman DC. “Exercise and cellular innate immune function.” Med Sci Sports Exerc. 1999; 31(1): 57-66.

260. Womble D, Helderman JH. “The impact of acemannan on the generation and function of cytotoxic T-lym­phocytes.” lmmunopharmacol Immunotoxicol.1992, 14(1-2): 63-77.

261. Wu hog Xing, Jiang jia Kun. “Clinical Study of P-TFOL Liquid Treating Hepatitis.” XIth International Congress on Transfer Factor, 1—4 MAR 1999, Monterrey, Mexico.

262. Whiteside TL, Herberman RB. “Role of human Natural Killer cells in health and disease.” Clin Diagn Lab Immunol. 1994; 1(2): 125-33.

263. Wilson GB, Paddock CV. “Process for obtaining transfer factor from colostrum transfer factor so obtained and use thereof.” US Patent Number 4816563; Mar. 28, 1989

264. Whiteside TL, Herherman RB. “Human Natural Killer cells in health and disease.” Biology and therapeutic potential. Clin Immunother. 1994; 1(1): 56-66.

265. Whiteside TL, Friberg D. “Natural Killer cells and Natural Killer cell activity in chronic fatigue syn­drome.” Am J Med. 1998; 105:3A, 27S-34S.

266. Wiseman SA, Mathot JN, de Fouw NJ, Tijburg LB. “Dietary non-tocopherol antioxidants present in extra virgin olive oil increase the resistance of low density lipoproteins to oxidation in rabbits.” Atherosclerosis 1996 , 120(1-2):15-23

267. Wu S, Zhong X. “Observation of the effect of PSTF oral liquor on the positive tuberculin test reaction.” Chung Kuo I Hsueh Ko Hsueh Yuan Hsueh Pao 1992; 14(4): 314-6.

268. Wilt TJ, MacDonald R, et al. “Beta-sitosterol for the treatment of benign prostatic hyperplasia: a systematic review.” BJU Int 1999, 83(9): 976-83

269. Wurzner R. “Evasion of pathogens by avoiding recognition or eradication by complement, in part via molecular mimicry.” Mol Immunol. 1999; 36(4-5): 249-60.

270. Xia Y, Vetvicka V, Yan J, Hanikyrova M, Mayadas T, Ross CD. “The beta-glucan-binding Lectin site of mouse CR3 (CD11b/CD18) and its function in generating a primed state of the receptor that mediates cytotoxic acti­vation in response to iC3b-opsonized target cells.” J Immunol. 1999; 162(4): 228, 1-90

271. Xia Y, Ross CD. “Generation of recombinant fragments of CDllb expressing the functional beta-glucan-binding lectin site of CR3 (CD1 1 b/CD18).” J Immunol. 1999; 162(12): 7285-93.

272. Xu RH, Peng XE, Chen CZ, Chen CL. “Effects of cordyceps sinensis on Natural Killer activity and colony formation of Bl6 melanoma.” Chin Med J (Engl). 1992; 105(2): 97-101.

273. Xu F, Huang JB, Jiang U, Xu J, Mi J. “Amelioration of cyclosporin nephrotoxicity by Cordyceps sinensis in kid­ney-transplanted recipients.” [letter] Nephrol Dial Transplant. 1995; 10(1): 142-3.

274. Yamaguchi N, Yoshida J, Ren U, Chen H, Miyazawa Y, Fujii Y, Huang YX, Takamura S, Suzuki S, Koshimura S, et al. “Augmentation of various immune reactivities of tumor-hearing hosts with an extract of Cordyceps sinensis.” Biotherapy. 1990; 2(3): 199-205.

275. Yan J, Vetvicka V, Xia Y, Coxon A, Carroll MC, Mayadas TN, Ross CD. “Beta-glucan, a ‘specific’ biologic response modifier that uses antibodies to target tumors for cytotoxic recognition by leukocyte complement receptor type 3 (CD11b/CD18).” J Immunol. 1999; 163(6): 3045-52.

276. Yang CY; Shamsuddin AM. “IP6-induced growth inhibition and differentiation of HT-29 human colon cancer cells: involvement of intracellular inositol phosphates.” Anticancer Res. 1995, 15:6B: 2479-87.

277. Yates KM, Rosenberg U, Harris CK, Bronstad DC, King CK, Biehle CA, Walker B, Ford CR, Hall JE, Tizard JR. “Pilot study of the effect of acemannan in cats infected with feline immunod­eficiency virus.” Vet-Immunol-Immunopathol.1992, 35(1-2), 177-89

278. Yates KM, Rosenberg U, Harris CK, Bronstad DC, King CK, Biehle CA, Walker B, Ford CR, Hall JE, Tizard JR. “Pilot study of the effect of acemannan in cats infected with feline immunod­eficiency virus.” Vet-Immunol-Immunopathol. 1992, 35(1-2): 177-89.

279. Yoshida J, Takamura S, Yamaguchi N, Ren U, Chen H, Koshirnura S, Suzuki S. “Antitumor activity of an extract of Cordyceps sinensis (Berk.) Sacc. against murine tumor cell lines.” Jpn J Exp Med, 1989; 59(4): 157-61

280. Zhou U, Yang W, Xu Y, Zhu Q, Ma Z, Zhu T, Ce X, Gao J. “Short-term curative effect of cultured Cordyceps sinensis (Berk.) Sacc. Mycelia in chronic hepatitis B.” Chung Kuo Chung Yao Tsa Chih. 1990; 15(1): 53-5, 65.

281. Zernikow B, Michel F, Fleischhack C, Bode U. “Accidental iatrogenic intoxications by cytotoxic drugs: error analysis and practical preventive strategies.” Drug Saf, 1999; 21(1): 57-74.

282. Zhu JS, Halpern CM, Jones K. “The scientific rediscovery of an ancient Chinese herbal medicine: Cordyceps sinensis: part I.” J Altern Complement Med, 1998; 4(3): 289-303.

283. Zhu JS, Halpern CM Jones K. “The scientific rediscovery of a precious ancient Chinese herbal regimen: Cordyceps sinensis: part II.” J Altern Complement Med. 1998; 4(4): 429-457.

284. Zhou DH, Lin UZ. “Effect of Jinshuibao capsule on the immunological function of 36 patients with advanced cancer.” Chung Kuo Chung Hsi I Chieh Ho Tsa Chih, 1995, 15:8, 476-8

285. Zhang U, Tizard JR. “Activation of a mouse macrophage cell line by acemannan: the major carbo­hydrate fraction from Aloe yera gel.” Immunopharmacology. 1996; 35(2): 119-28.

286. Zhu JS, Halpern CM Jones K. “The scientific rediscovery of a precious ancient Chinese herbal regimen: Cordyceps sinensis: part II.” J Altern Complement Med. 1998; 4(4): 429-457.

287. Zhen F, Tian J, Li US. “Mechanisms and therapeutic effect of Cordyceps sinensis (CS) on aminogly­coside induced acute renal failure (ARE) in rats.” Chung Kuo Chung Hsi I Chieh Ho Tsa Chih. 1992; 12(5): 288-91, 262.

288. Zhao X, Li L. “Cordyceps sinensis in protection of the kidney from cyclosporine A nephro­toxicity.” Chung Hua I Hsueh Tsa Chih. 1993; 73(7): 410-2, 447.

289. Zhu XY, Yu HY. “Immunosuppressive effect of cultured Cordyceps sinensis on cellular immune response.” Chung Hsi I Chieh Ho Tsa Chih, 1990; 10(Cool: 485-7,454.
Вернуться к началу Перейти вниз
 
Библиография
Вернуться к началу 
Страница 1 из 1

Права доступа к этому форуму:Вы не можете отвечать на сообщения
Будем здоровы :: Трансфер фактор :: Статьи-
Перейти:  
Создать форум | © phpBB | Бесплатный форум поддержки | Контакты | Сообщить о нарушении | Последние обсуждения